MTOR and familial pancreatic carcinoma: Interestingly, the survival curves generated from RNA-sequencing (RNA-seq) database of the Cancer Genome Atlas (TCGA) also demonstrated that a higher mTOR expression level is correlated with an overall poorer survival in colon, breast, lung, and pancreatic cancer patients (Supplementary Figure S1).